In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Global Corporate Insurer Projects Increased Liability For ‘Toxic Trio’ Use In Cosmetics

This article is powered by The Rose Sheet

Executive Summary

Allianz Global Corporate and Specialty raises liability concerns that could be relevant to cosmetics manufacturers still using “toxic trio” ingredients. The firm’s report is a signal at least that rampant US litigation for alleged false advertising and undeclared ingredient risks has reached the international insurance consciousness.


Related Content

California DTSC Selects Toluene In Nail Care For Potential Phase-Out
Nail Polishes Contain Undeclared DEHP, Among Other ‘Regrettable Substitutions’ – Study
J&J Hopes To Continue Appellate Streak Following Whopping $4.69bn Talc Verdict
EU Watch: Three Cosmetics-Relevant Areas Targeted For Imminent Policy Development
California DTSC Official Says Nail Care Will Remain SCP Focus Area; Stakeholders Stay Tuned
L’Oreal Hair-Relaxer Class Action A Far Cry From WEN, Or Next Plaintiff Payout?
Mislabeled Nail Polishes Warrant Increased Regulation – California DTSC
Campaign For Safe Cosmetics To Keep Pushing For Product Reformulation In 2012


Related Companies




Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts